Increasing Tysabri dosing interval may cut PML risk
Increasing Tysabri dosing interval may cut PML risk
Freedom from relapse was maintained in multiple sclerosis patients on Tysabri who received the infusion drug less frequently than the recommended 4-week interval, with lower risk of progressive multifocal leukoencephalopathy (PML), preliminary results from an ongoing analysis have indicated...... Read More - http://www.ms-uk.org/tysabri
MS-UK - http://www.ms-uk.org/
Re: Increasing Tysabri dosing interval may cut PML risk
Prior to any flag waving, please note that this is not a randomized double blind controlled trial...
Weinshenker commented that selection of patients for extended dosing, which was not random, might have involved "biases against committing more aggressive MS patients on the extended interval program, which might reduce the ability of the investigators to detect reduction in efficacy."
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2377 Views
-
Last post by NHE
-
- 6 Replies
- 6868 Views
-
Last post by ElliotB
-
- 0 Replies
- 3525 Views
-
Last post by NHE
-
- 0 Replies
- 1396 Views
-
Last post by NHE
-
- 1 Replies
- 1573 Views
-
Last post by NHE
-
- 11 Replies
- 3441 Views
-
Last post by NHE
-
- 1 Replies
- 1067 Views
-
Last post by NHE
-
- 0 Replies
- 3250 Views
-
Last post by NHE
-
- 0 Replies
- 1504 Views
-
Last post by NHE